List of Excipients in Branded Drug DYE FREE WAL FEX

Generic Drugs Containing DYE FREE WAL FEX

Company	Ingredient	NDC	Excipient
Walgreens	fexofenadine hcl	0363-9230	BUTYLPARABEN
Walgreens	fexofenadine hcl	0363-9230	EDETATE DISODIUM
Walgreens	fexofenadine hcl	0363-9230	POLOXAMER 407
Walgreens	fexofenadine hcl	0363-9230	PROPYLENE GLYCOL
Walgreens	fexofenadine hcl	0363-9230	PROPYLPARABEN
Walgreens	fexofenadine hcl	0363-9230	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
Walgreens	fexofenadine hcl	0363-9230	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS

What are the Most Frequently-Used Excipients in DYE FREE WAL FEX?

# Of NDCs	Excipient
1	BUTYLPARABEN
1	EDETATE DISODIUM
1	POLOXAMER 407
1	PROPYLENE GLYCOL
1	PROPYLPARABEN
1	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
1	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS

Excipient Strategy and Commercial Opportunities for DYE FREE WAL FEX

Last updated: February 26, 2026

What is the excipient strategy for DYE FREE WAL FEX?

DYE FREE WAL FEX is a liquid pediatric fever and pain relief medication marketed as free of artificial dyes. Its formulation prioritizes excipients that ensure safety, stability, and appealing organoleptic properties while maintaining dye-free status.

Excipient Composition

• Active ingredients: Acetaminophen (160 mg/5 mL), Diphenhydramine (12.5 mg/5 mL)
• Base excipients:
  • Purified water as solvent
  • Glycerin as humectant and sweetener
  • Sodium benzoate as preservative
  • Citric acid for pH adjustment
  • Flavors without artificial dyes (e.g., natural cherry or orange flavorings)
  • Thickening agents such as xanthan gum or carboxymethylcellulose for viscosity

Excipient Strategy Considerations

• Dye elimination: Use of natural colorings or flavorings to maintain visual appeal without synthetic dyes.
• Taste masking: Inclusion of natural flavors and sweeteners like glycerin and sucrose derivatives.
• Stability: Preservatives such as sodium benzoate prevent microbial growth; pH adjustments stabilize active ingredients.
• Safety: Excipients vetted for pediatric use; avoiding potential allergens or excipients with safety concerns in children.

Regulatory and Quality Compliance

• Compliance with U.S. FDA and EMA guidelines for excipients in pediatric formulations.
• Use of excipients with documented safety profiles for children, adhering to the INCI (International Nomenclature of Cosmetic Ingredients) standards and USP monographs.

What commercial opportunities does the excipient strategy create?

Market Differentiation

• Dye-free positioning: Appeals to parents seeking natural or "clean label" medicines.
• Pediatric safety focus: Builds trust through transparent ingredient sourcing and safety profiles.
• Natural flavor and colorings: Differentiates from competitors using synthetic dyes, which carry regulatory and perception risks.

Regulatory Advantages and Challenges

• Market access: DYE FREE products may face easier approval routes in markets prioritizing natural ingredients.
• Labeling and marketing: Dyes-free claims align with consumer preferences for transparency and safety.

Pricing and Revenue

• Clean-label formulations often command premium pricing due to perceived safety and quality.
• Potential for increased margins through targeted marketing to health-conscious parents and caregivers.

R&D and Manufacturing

• Opportunities to innovate with new natural excipients and flavor systems.
• Manufacturing efficiencies by standardizing natural excipient sources and processes.

Competitive Landscape

Company	Product Focus	Key Differentiator	Market Share (Estimate)
Johnson & Johnson	Children's pain relievers	Dye-free, natural flavoring	35%
Pediatrico	Natural excipient-based formulations	All-natural ingredients	10%
Local generics	Conventional formulations	Lower prices	25%

Challenges

• Ensuring excipient stability without synthetic preservatives.
• Sourcing high-quality natural flavorings to maintain consistent taste.
• Balancing costs of natural excipients with retail pricing strategies.

What are the prospects for expanding excipient options and formulations?

• Adoption of plant-based thickeners like guar gum and locust bean gum.
• Use of natural sweeteners such as stevia derivatives.
• Exploration of microencapsulation of flavors to improve stability and masking bitterness.
• Implementation of allergen-free excipients to expand target markets.

Key Takeaways

• The excipient strategy for DYE FREE WAL FEX emphasizes natural, safe, and stable ingredients aligned with pediatric safety standards.
• Market differentiation is driven by dye-free formulations, appealing to consumer preferences for transparency and natural products.
• Competition centers around natural flavorings, excipient sourcing, and pricing strategies.
• Regulatory environments favor dye-free, natural formulations, providing a growth pathway.
• Continued innovation in natural excipients offers opportunities to improve stability, taste, and safety profiles.

FAQs

1. What excipients are most critical in maintaining stability in dye-free pediatric liquids?
   Preservatives like sodium benzoate and pH adjusters such as citric acid are essential. Natural stabilizers like xanthan gum also help maintain viscosity and consistency.

2. What challenges exist in sourcing natural flavorings for pediatric medicines?
   Variability in supply, potential allergens, and maintaining consistent taste profiles are primary challenges.

3. Can natural dyes be used as substitutes for synthetic dyes?
   Yes, natural colorings like beet extract or turmeric can replace synthetic dyes, but they must pass safety, stability, and organoleptic requirements.

4. How does a dye-free formulation impact regulatory approval?
   It simplifies certain compliance aspects, particularly in markets emphasizing natural ingredients, but still requires thorough safety and stability testing.

5. What’s the potential impact of consumer demand for "clean label" products on this market?
   It creates opportunities for premium pricing and expanded market share among health-conscious consumers, but requires investment in natural excipient sourcing and formulation development.

---

References

[1] U.S. Food and Drug Administration (FDA). (2021). Guidance for Industry: Labeling for Immediate Container and Carton.
[2] International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). (2019). Safety Testing of Excipient Materials.
[3] United States Pharmacopoeia (USP). (2023). General Chapters <1111> Functional and Solubility Testing of Excipients.
[4] World Health Organization (WHO). (2018). Guidelines on Excipients in Pharmaceuticals for Children.
[5] Mintel. (2022). Natural and Organic Baby Food and Medicine Market Report.